4//SEC Filing
Happel David 4
Accession 0001209191-17-058085
CIK 0001492426other
Filed
Oct 25, 8:00 PM ET
Accepted
Oct 26, 7:39 PM ET
Size
9.0 KB
Accession
0001209191-17-058085
Insider Transaction Report
Form 4
Happel David
EVP Global Orphan Bus. Unit
Transactions
- Exercise/Conversion
Restricted Stock Units
2017-10-25−7,953→ 23,860 total→ Ordinary Shares (7,953 underlying) - Tax Payment
Ordinary Shares
2017-10-25$13.53/sh−4,150$56,150→ 5,089 total - Exercise/Conversion
Ordinary Shares
2017-10-25+7,953→ 9,239 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F2]Includes 1,286 ordinary shares of the Issuer acquired by the reporting person on June 1, 2017 pursuant to an employee stock purchase program.
- [F3]On October 25, 2016, the reporting person was granted an aggregate of 31,813 restricted stock units. The restricted stock units vest in four equal annual installments beginning on October 25, 2017.
Documents
Issuer
Horizon Pharma plc
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001623567
Filing Metadata
- Form type
- 4
- Filed
- Oct 25, 8:00 PM ET
- Accepted
- Oct 26, 7:39 PM ET
- Size
- 9.0 KB